Novel Mutation of NOTCH3 Gene in a Chinese Patient with CADASIL
References
- Cannistraro RJ, Badi M, Eidelman BH, Dickson DW, Middlebrooks EH, Meschia JF. CNS small vessel disease: A clinical review. Neurology. 2019;92:1146–56.
- Schoemaker D, Quiroz YT, Torrico-Teave H, Arboleda-Velasquez JF. Clinical and research applications of magnetic resonance imaging in the study of CADASIL. Neurosci Lett. 2019;698:173–9.
- Yuan L, Chen X, Jankovic J, Deng H. CADASIL: A NOTCH3-associated cerebral small vessel disease. J Adv Res. 2024;66:223–35.
- Heidari P, Taghizadeh M, Vakili O. Signaling pathways and molecular mechanisms involved in the onset and progression of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL); a focus on Notch3 signaling. J Headache Pain. 2025;26:96.
- Felix-Ilemhenbhio F, Kocsy K, Azzouz M, Majid A. The role of NOTCH3 in CADASIL pathogenesis: insights into novel therapies. Brain Res. 2025;1863:149754.
- Wang MM. CADASIL. Handb Clin Neurol. 2018;148:733–43.
- Di Donato I, Bianchi S, De Stefano N, Dichgans M, Dotti MT, Duering M, et al. Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) as a model of small vessel disease: update on clinical, diagnostic, and management aspects. BMC Med. 2017;15:41.
- He D, Chen D, Li X, Hu Z, Yu Z, Wang W, et al. The comparisons of phenotype and genotype between CADASIL and CADASIL-like patients and population-specific evaluation of CADASIL scale in China. J Headache Pain. 2016;17:55.
- Liem MK, Oberstein SA, van der Grond J, Ferrari MD, Haan J. CADASIL and migraine: A narrative review. Cephalalgia. 2010;30:1284–9.
- Wang YF. Is migraine a common manifestation of CADASIL-Cons. J Headache Pain. 2025;26:65.
- Romay MC, Knutsen RH, Ma F, Mompeón A, Hernandez GE, Salvador J, et al. Age-related loss of Notch3 underlies brain vascular contractility deficiencies, glymphatic dysfunction, and neurodegeneration in mice. J Clin Invest. 2024;134.
- Markus HS, Martin RJ, Simpson MA, Dong YB, Ali N, Crosby AH, et al. Diagnostic strategies in CADASIL. Neurology. 2002;59:1134–8.
- O’Sullivan M, Jarosz JM, Martin RJ, Deasy N, Powell JF, Markus HS. MRI hyperintensities of the temporal lobe and external capsule in patients with CADASIL. Neurology. 2001;56:628–34.
- Tasharrofi B, Najafi A, Pourbakhtyaran E, Amirsalari S, Khan GS, Ashrafi MR, et al. Distinct neurological phenotypes associated with biallelic loss of NOTCH3 function: evidence for recessive inheritance. Mol Biol Rep. 2024;51:714.
- He M, Peng Q, Yang Q, Guan X, Liu Q, Chen R, et al. In situ reprogramming of tumor associated macrophages with versatile nano-epigenetic inhibitor for lung cancer therapy. J Control Release. 2026;390:114497.
- Lesnik Oberstein SA, van den Boom R, van Buchem MA, van Houwelingen HC, Bakker E, Vollebregt E, et al. Cerebral microbleeds in CADASIL. Neurology. 2001;57:1066–70.
- Nannucci S, Rinnoci V, Pracucci G, MacKinnon AD, Pescini F, Adib-Samii P, et al. Location, number and factors associated with cerebral microbleeds in an Italian-British cohort of CADASIL patients. PLoS One. 2018;13:e0190878.
- Puy L, De Guio F, Godin O, Duering M, Dichgans M, Chabriat H, et al. Cerebral Microbleeds and the Risk of Incident Ischemic Stroke in CADASIL (Cerebral Autosomal Dominant Arteriopathy With Sub-cortical Infarcts and Leukoencephalopathy). Stroke. 2017;48:2699–703.
- Lee JS, Ko K, Oh JH, Park JH, Lee HK, Floriolli D, et al. Cerebral Microbleeds, Hypertension, and Intracerebral Hemorrhage in Cerebral Autosomal-Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy. Front Neurol. 2017;8:203.
- Liao YC, Hsiao CT, Fuh JL, Chern CM, Lee WJ, Guo YC, et al. Characterization of CADASIL among the Han Chinese in Taiwan: Distinct Genotypic and Phenotypic Profiles. PLoS One. 2015;10:e0136501.
- Chung CP, Chen JW, Chang FC, Li WC, Lee YC, Chen LF, et al. Cerebral Microbleed Burdens in Specific Brain Regions Are Associated With Disease Severity of Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy. J Am Heart Assoc. 2020;9:e016233.
- Akrich M, Rabeharisoa V, Paterson F, Chabriat H. Genetic diagnosis of individuals at risk of CADASIL: prospect for future therapeutic development. J Neurol. 2024;271:6912–22.
- Liu JY, Yao M, Dai Y, Han F, Zhai FF, Zhang DD, et al. Rare NOTCH3 Variants in a Chinese Population-Based Cohort and Its Relationship With Cerebral Small Vessel Disease. Stroke. 2021;52:3918–25.
- Boston G, Jobson D, Mizuno T, Ihara M, Kalaria RN. Most common NOTCH3 mutations causing CADASIL or CADASIL-like cerebral small vessel disease: A systematic review. Cereb Circ Cogn Behav. 2024;6:100227.
- Joutel A. The Pathobiology of Cerebrovascular Lesions in CADASIL Small Vessel Disease. Basic Clin Pharmacol Toxicol. 2025;136:e70028.
- Iruzubieta P, Alves C, Al Shamsi AM, ElGhazali G, Zaki MS, Pinelli L, et al. Clinical and neuroradiological spectrum of biallelic variants in NOTCH3. EBioMedicine. 2024;107:105297.
- Dotti MT, De Stefano N, Bianchi S, Malandrini A, Battisti C, Cardaioli E, et al. A novel NOTCH3 frame-shift deletion and mitochondrial abnormalities in a patient with CADASIL. Arch Neurol. 2004;61:942–5.
- Schubert V, Bender B, Kinzel M, Peters N, Freilinger T. A novel frameshift variant in the CADASIL gene NOTCH3: pathogenic or not? J Neurol. 2018;265:1338–42.
- Ouskri A, Ihlal H, En-Nasery Z, Chaouki S, Bouguenouch L, Ouldim K, et al. A novel homozygous loss-of-function NOTCH3 variant in a Moroccan patient: expanding the spectrum beyond CADASIL. Neurogenetics. 2025;26:80.
DOI: https://doi.org/10.2478/bjmg-2025-00025 | Journal eISSN: 2199-5761
Language: English
Page range: 113 - 120
Published on: May 14, 2026
Published by: Macedonian Academy of Sciences and Arts
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Keywords:
Related subjects:
© 2026 JX Lin, X Gao, LJ Hou, XY Zhang, X Zhang, XM Liu, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.